Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000153559 | SCV000203090 | benign | not specified | 2014-02-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000552111 | SCV000636711 | benign | Nance-Horan syndrome | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336312 | SCV002638989 | benign | Inborn genetic diseases | 2017-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001723719 | SCV001958140 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000153559 | SCV001969679 | benign | not specified | no assertion criteria provided | clinical testing |